What does MEDICEVER do?

MEDICEVER is a general practice in Evere. Private Limited, started on 3 June 1998, 1 establishment.

What is the address of MEDICEVER?

The registered office of MEDICEVER is located at Jaak Ballingsstraat 46, 1140 Evere.

Is MEDICEVER still active?

Yes. According to the CBE (31 October 2026) MEDICEVER is active, legal situation “Normale toestand”, started on 3 June 1998.

Is MEDICEVER registered on Peppol?

Yes, MEDICEVER is registered on the Peppol network with ID 0208:0463477975.

What is the enterprise number of MEDICEVER?

The enterprise number of MEDICEVER is BE0463477975.

When was MEDICEVER founded?

MEDICEVER was founded on 3 June 1998.

Is MEDICEVER a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 June 1998; 5 annual accounts filed, latest fiscal year 2025.

How much profit did MEDICEVER make in 2025?

MEDICEVER recorded a loss after taxes of € 12,002 in financial year 2025.

What is the revenue of MEDICEVER?

As a small company, MEDICEVER is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 45,448.

MEDICEVER (Private Limited) - Evere - BE0463477975

Dossier MEDICEVER, printed on 31 October 2026 from databakkes.be/en/0463477975/medicever. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDICEVER from Evere, company number BE0463477975, closed financial year 2025 with a result of € -12,002 after tax. For that financial year MEDICEVER recorded a gross margin of € 45,448 and equity of € 311,426. Compared with financial year 2024, the result moved from € 48,889 to € -12,002. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Healthy

€ 311,426

▼ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -12,002

▼ still € 48,889 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1,663

▼ 88% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 292,834.

People and assets in 2025

Wage cost

€ 40,702

▲ 40% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5,881

▼ 31% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 5,057

▼ 1% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 4,693

▲ € 4,384 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 31,884

▲ 149% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2021	2023	2024	2025	Change 2024 → 2025
Revenue	-	€ 246,635 Revenue 2023: € 246,635 First fiscal year in the series	-	-
Gross margin	€ 182,450 Gross margin 2021: € 182,450 First fiscal year in the series	€ 101,050 Gross margin 2023: € 101,050 ▼ 45% vs 2021 (€ 182,450) Unfavourable step	€ 134,273 Gross margin 2024: € 134,273 ▲ 33% vs 2023 (€ 101,050) Favourable step	€ 45,448 Gross margin 2025: € 45,448 ▼ 66% vs 2024 (€ 134,273) Unfavourable step	▼ 66%
Profit after taxes	€ 98,490 Profit after taxes 2021: € 98,490 First fiscal year in the series	€ 27,597 Profit after taxes 2023: € 27,597 ▼ 72% vs 2021 (€ 98,490) Unfavourable step	€ 48,889 Profit after taxes 2024: € 48,889 ▲ 77% vs 2023 (€ 27,597) Favourable step	€ -12,002 Profit after taxes 2025: € -12,002 ▼ € 60,891 vs 2024 (€ 48,889) Unfavourable step	▼ € 60,891
Equity	€ 216,949 Equity 2021: € 216,949 First fiscal year in the series	€ 273,737 Equity 2023: € 273,737 ▲ 26% vs 2021 (€ 216,949) Favourable step	€ 323,428 Equity 2024: € 323,428 ▲ 18% vs 2023 (€ 273,737) Favourable step	€ 311,426 Equity 2025: € 311,426 ▼ 4% vs 2024 (€ 323,428) Unfavourable step	▼ 4%
Total debts	€ 54,166 Total debts 2021: € 54,166 First fiscal year in the series	€ 22,118 Total debts 2023: € 22,118 ▼ 59% vs 2021 (€ 54,166) Favourable step	€ 19,106 Total debts 2024: € 19,106 ▼ 14% vs 2023 (€ 22,118) Favourable step	€ 41,982 Total debts 2025: € 41,982 ▲ 120% vs 2024 (€ 19,106) Unfavourable step	▲ 120%
Cash	€ 54,516 Cash 2021: € 54,516 First fiscal year in the series	€ 10,017 Cash 2023: € 10,017 ▼ 82% vs 2021 (€ 54,516) Unfavourable step	€ 14,349 Cash 2024: € 14,349 ▲ 43% vs 2023 (€ 10,017) Favourable step	€ 1,663 Cash 2025: € 1,663 ▼ 88% vs 2024 (€ 14,349) Unfavourable step	▼ 88%
Land & buildings	-	€ 18,263 Land & buildings 2023: € 18,263 First fiscal year in the series	€ 29,577 Land & buildings 2024: € 29,577 ▲ 62% vs 2023 (€ 18,263) Unchanged	€ 21,059 Land & buildings 2025: € 21,059 ▼ 29% vs 2024 (€ 29,577) Unchanged	▼ 29%
Retained profit	€ 198,357 Retained profit 2021: € 198,357 First fiscal year in the series	€ 255,145 Retained profit 2023: € 255,145 ▲ 29% vs 2021 (€ 198,357) Favourable step	€ 304,836 Retained profit 2024: € 304,836 ▲ 19% vs 2023 (€ 255,145) Favourable step	€ 292,834 Retained profit 2025: € 292,834 ▼ 4% vs 2024 (€ 304,836) Unfavourable step	▼ 4%
Bank debt	€ 1,586 Bank debt 2021: € 1,586 First fiscal year in the series	€ 5,065 Bank debt 2023: € 5,065 ▲ 219% vs 2021 (€ 1,586) Unfavourable step	€ 5,092 Bank debt 2024: € 5,092 ▲ 1% vs 2023 (€ 5,065) Unfavourable step	€ 5,057 Bank debt 2025: € 5,057 ▼ 1% vs 2024 (€ 5,092) Favourable step	▼ 1%
Balance sheet total	€ 271,115 Balance sheet total 2021: € 271,115 First fiscal year in the series	€ 295,855 Balance sheet total 2023: € 295,855 ▲ 9% vs 2021 (€ 271,115) Unchanged	€ 342,534 Balance sheet total 2024: € 342,534 ▲ 16% vs 2023 (€ 295,855) Unchanged	€ 353,408 Balance sheet total 2025: € 353,408 ▲ 3% vs 2024 (€ 342,534) Unchanged	▲ 3%

Key figures of MEDICEVER, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDICEVER?

What happened at MEDICEVER in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: loss of € 12,002 (▼ € 60,891 vs 2024). filed late Source: NBB ↗
Jun 3, 1998 Start of the company according to the CBE. KBO
Jun 2, 1998 New establishment in Evere. KBO

In short

From € 98,490 profit in 2021 to € 12,002 loss in 2025.

Paid € 94,202 in corporate taxes since 2021.

Best year ever: 2021, with € 98,490 profit.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Jaak Ballingsstraat 46

1140 Evere

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0463.477.975

VAT number

BE 0463.477.975

Registered office

Jaak Ballingsstraat 46, 1140 Evere

Names & denominations

MEDICEVER

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

3 June 1998

Peppol

Active · Active since 28 Nov 2024

Activities · NACE

Activiteiten van huisartspraktijken

Medische praktijken

View on CBE Public ↗ Annual accounts (NBB) ↗